Rev Med.Co
1 known investors
REV-MED is a South Korean biotechnology company developing technology to separate and concentrate blood, bone marrow, and fat cells from the human body. It focuses on regenerative medicine, cell therapy solutions, and pharmaceutical/biotech development.
Investors · 1
Frequently asked questions
- What does Rev Med.Co do?
- REV-MED is a South Korean biotechnology company developing technology to separate and concentrate blood, bone marrow, and fat cells from the human body. It focuses on regenerative medicine, cell therapy solutions, and pharmaceutical/biotech development.
- Who are Rev Med.Co's investors?
- Rev Med.Co's investors include Aju IB Invesment Corporation.